Back to Search
Start Over
How can we improve the outcome for transplant patients with nontuberculous mycobacterial infections?
- Source :
-
Future microbiology [Future Microbiol] 2018 Jun 01; Vol. 13, pp. 903-914. Date of Electronic Publication: 2018 Jun 11. - Publication Year :
- 2018
-
Abstract
- Nontuberculous mycobacteria (NTM) are environmental organisms that are rapidly emerging as pathogens in the transplant population. The prevalence of infection in transplant recipients remains unknown. While guidelines exist for treatment of NTM, neither the American Thoracic Society, the Infectious Diseases Society of America, nor the British Thoracic Society guidelines dictate the approach needed for transplant recipients. Here, we summarize risk factors, important diagnostic and treatment facts, and preventive measures to be taken to help improve outcomes of those infected with NTM infections.
- Subjects :
- Humans
Mycobacterium Infections, Nontuberculous etiology
Mycobacterium Infections, Nontuberculous prevention & control
Mycobacterium abscessus physiology
Organ Transplantation statistics & numerical data
Postoperative Complications etiology
Postoperative Complications prevention & control
Stem Cell Transplantation statistics & numerical data
Treatment Outcome
Mycobacterium Infections, Nontuberculous microbiology
Organ Transplantation adverse effects
Postoperative Complications microbiology
Stem Cell Transplantation adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 1746-0921
- Volume :
- 13
- Database :
- MEDLINE
- Journal :
- Future microbiology
- Publication Type :
- Academic Journal
- Accession number :
- 29888973
- Full Text :
- https://doi.org/10.2217/fmb-2018-0006